Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Clinical trial NCT03813836 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03813836
Sponsor: University College, London
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2019-07-05
Primary completion: 2024-01-10
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.